Daniel Miller is a biomedical consultant and researcher with a focus on genetics and gene therapies for neuromuscular conditions. He obtained a Ph.D. and M.D. degree from the University of Washington, where he studied the mechanisms of cell transduction by retroviral vectors. After completing a pediatric residency and a fellowship in medical genetics, he worked as a post-doctoral fellow, studying the use of viral vectors for gene targeting and cellular mechanisms involving integration of vector sequences into the human genome. Daniel Miller's lab at the University of Washington currently studies molecular engineering in two diseases, including epidermolysis bullosa, where they apply gene targeting strategies for dominantly inherited genetic diseases.